CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to ONC

Oxaliplatin

Phase 3
BeOne Medicines Ltd. (ONC)

Phase 3

Development Phase

0

Upcoming Catalysts

1

Historical Events

0

Regulatory Approvals

Development History
Sep '26
ONCPhase 3

Oxaliplatin Phase 3 Est. Readout

Oxaliplatin
Sep 2026~
CT.gov
00%
Competitive Landscape

0 competitors in Advanced Unresectable Gastric Adenocarcinoma

View Full Landscape
Drug Information

Target Indication

Advanced Unresectable Gastric Adenocarcinoma

Clinical Trial

NCT07554521

Last updated: 10/16/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.